Healt
Recce Pharmaceuticals Expands Global Reach with Japanese Patent Approval
February 26, 2025 01:59 PM AEDT| By Team Kalkine MediaHighlights,Recce Pharmaceuticals (RCE) secures a new patent in Japan, extending protection until 2041.,Japan’s pharmaceutical market ranks third globally, with rising demand for anti-infective therapies.,Patent covers RECCE® 327 and RECCE® 529, targe...
Sonic Healthcare's (ASX:SHL) First Half 2025 Results Show Steady Growth and Margin Expansion
February 26, 2025 01:53 PM AEDT| By Team Kalkine MediaHighlights,Revenue reaches AU$4.67 billion, marking an 8.4% increase year-over-year.,Net income rises 17% to AU$236.7 million, improving profit margins.,Revenue growth projections align with industry trends in Australia.,f 2025, demonstrating steady...
PolyNovo (ASX:PNV) Reports First Half 2025 Financial Results
February 26, 2025 01:39 PM AEDT| By Team Kalkine MediaHighlights,Revenue increases by 26% compared to 1H 2024,Profit margin slightly decreases to 5.6%,EPS improves from AU$0.004 to AU$0.005,PolyNovo (,ASX:PNV,) has released its first half 2025 financial results, showcasing a strong growth in revenues. T...
Patrys First Half 2025 Earnings Report: Loss of AU$0.001 per share, consistent with the AU$0.001 loss in the first half of 2024.
February 26, 2025 01:32 PM AEDT| By Team Kalkine MediaHighlights:,Revenue experienced an increase compared to the same period last year,Net loss showed a notable decline, reflecting improved financial performance,Shares experienced an upward trend over the past week,Patrys Limited (ASX:PAB),, operating...
AI platform Decidr partners with Go1 to enhance corporate learning
February 26, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Decidr Industries (ASX:DAI) partners with Go1 to enhance AI-driven career development solutions.,The partnership aims to integrate Decidr’s AI technology into Go1’s extensive learning platform, offering customized upskilling and career pat...
Regis Healthcare Limited: Sustained Growth and Market Performance
February 25, 2025 03:30 PM AEDT| By Team Kalkine MediaHighlights:,Consistent Revenue Expansion:,Growth trends play a crucial role in shaping market valuation.,Dividend Impact on Returns:,Shareholder returns are significantly influenced by dividend distributions.,Market Performance Trends:,Share price mo...
Steady Dividend Growth: Sonic Healthcare (ASX:SHL) Enhances Shareholder Returns
February 25, 2025 01:58 PM AEDT| By Team Kalkine MediaHighlights,Sonic Healthcare (SHL) to distribute a dividend of A$0.44 per share.,Attractive,yield of 3.8% enhances shareholder returns.,Consistent 10-year history of steady dividend growth.,Sonic Healthcare (ASX:SHL) has announced an upcoming dividend...
Earnings Surge and Valuation Concerns: A Closer Look at PolyNovo’s Performance
February 25, 2025 01:56 PM AEDT| By Team Kalkine MediaHighlights,PolyNovo,(,ASX:PNOV,) shares,drop,14.7% in early trading.,First-half results show a,strong,increase in net profit and revenue.,Revised forecasts reflect challenges from currency and market pressures.,PolyNovo (ASX:PNOV), a leading medical...
Cryosite's First Half 2025 Financials: A Detailed Look
February 25, 2025 01:37 PM AEDT| By Team Kalkine MediaHighlights,Cryosite's revenue rises 3.7% to AU$6.64m.,Net income remains steady at AU$838.0k.,Shares increase by 14% in the past week.,The recent financial release by Cryosite (ASX:CTE) for the first half of 2025 reveals a 3.7% increase in revenue, a...
Nanosonics Limited (ASX:NAN): A Closer Look at Recent Stock Activity
February 25, 2025 01:37 PM AEDT| By Team Kalkine MediaHighlights,Nanosonics shares surge 26% in the past month,The company's P/S ratio stands at 7.7x, above industry norms,Future revenue growth aligns closely with industry expectations,Nanosonics Limited, with the ticker (ASX:NAN), has experienced a rem...
Firebrick Pharma (ASX:FRE) First Half 2025 Financial Overview
February 25, 2025 01:33 PM AEDT| By Team Kalkine MediaHighlights,Significant revenue drop to AU$197.1k from 1H 2024.,Net loss increased by 61% from the previous year.,Shares gained a slight increase over the past week.,The financial landscape of Firebrick Pharma (ASX:FRE) for the First Half of 2025 reve...
Cambium sees a 43% surge following FDA approval for Phase 3 trial of Elate Ocular.
February 25, 2025 12:30 PM AEDT| By Team Kalkine MediaHighlights,FDA-approved Phase 3 trial for an innovative ocular therapy.,Nearly 800 participants enrolled across multiple countries.,Potential to transform treatment for moderate to severe dry eye disease.,In the competitive landscape of biotechnology...
Next Science's stock drops following an FDA warning letter suggesting that their product might have led to injuries.
February 25, 2025 12:30 PM AEDT| By Team Kalkine MediaHighlights,FDA warning led to a 13% drop in Next Science shares.,Quality system and reporting issues were identified.,Misleading marketing practices raised compliance concerns.,The biotechnology sector is a dynamic and innovative industry, focused on...
Aroa's Sheep-Derived Products Reach Milestone with Seven Million Medical Uses
February 25, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Aroa Biosurgery’s soft-tissue regeneration products have been used in medical procedures worldwide, surpassing a major usage milestone.,The company’s extracellular matrix technology, derived from New Zealand sheep rumen, continues to advan...
EZZ Life Science Expands into US Market with Key Manufacturing Deal
February 25, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,EZZ Life Science enters agreement with GLSP Inc to manufacture dietary supplements in the US, aligning with FDA and ISO-certified standards.,The partnership facilitates EZZ's plan for US market entry in H2 FY25, ensuring improved productio...
Beamtree Holdings reported a loss of AU$0.011 per share for the first half of 2025, consistent with the AU$0.011 loss per share recorded in the first half of 2024.
February 24, 2025 07:38 PM AEDT| By Team Kalkine MediaHighlights:,Revenue increased to AU$14.2 million, reflecting an upward trend from the prior year.,Net loss expanded to AU$3.25 million, while the loss per share remained unchanged.,The share price has declined over the past week.,Beamtree Holdings, l...
Visionflex Group First Half 2025 Earnings: Loss of AU$0.001 per share (compared to a loss of AU$0.001 in the first half of 2024)
February 24, 2025 07:38 PM AEDT| By Team Kalkine MediaHighlights:,Visionflex Group’s revenue saw a notable decrease from the previous year.,Net loss expanded significantly compared to the same period last year.,Share price remained stable despite financial challenges.,Visionflex Group (ASX:VFX),operates...
Cochlear Limited (ASX:COH) Unpacking Financial Strength and Insider Confidence
February 24, 2025 01:32 PM AEDT| By Team Kalkine MediaCochlear Limited (ASX:COH) Unpacking Financial Strength and Insider Confidence
Cogstate (ASX:CGS) Reports Strong Financial Results for First Half 2025
February 24, 2025 01:32 PM AEDT| By Team Kalkine MediaCogstate (ASX:CGS) Reports Strong Financial Results for First Half 2025
INOVIQ's Intriguing First Half 2025 Financial Trajectory
February 24, 2025 01:30 PM AEDT| By Team Kalkine MediaINOVIQ's Intriguing First Half 2025 Financial Trajectory
Advertise your brand on Kalkine Media